To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

DIABETES DRUG PRICING

TODAY'S HEADLINES

Insulin makers accused of price collusion

US congressmen last week asked the Department of Justice and the Federal Trade Commission to investigate three insulin makers for price collusion. Read more

Diabetes increases risk of heart attack by half

Diabetes increases the risk of heart attack death by 50%, according to a new study that included more than 120,000 patients with diabetes. Read more

CONTINUING PHARMACY EDUCATION

Rheumatoid arthritis: partnering for optimal care

This month's CE activity, "Rheumatoid arthritis: partnering for optimal care," is open for pharmacists and pharmacy technicians.
The goal of this activity is to educate pharmacists and pharmacy technicians in how to best assist patients in the use of medications to treat rheumatoid arthritis.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Aggressive blood sugar control slows diabetic eye disease progression

Intensive glycemic control may reduce the risk of retinopathy progression in people with type 2 diabetes by half, according to a new study. Read more

November 09, 2016

Related Articles

Drug maker pays out millions over EpiPen charges

Empowered patients more likely to stick to diabetes treatments

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us